Company Directory / Biotechnology Research

Recursion Pharmaceuticals logo

Public · NASDAQ:RXRXFor profitBiotechnology ResearchSalt Lake City, Utah, United States

Recursion Pharmaceuticals

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Founded
2013
13 years ago
Staff
501-1000
915 on LinkedIn
Followers
65k
on LinkedIn
Funding
$865M
as listed, USD

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By… Read all

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale, up to millions of wet lab experiments weekly, and massive computational scale, owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal, New York, London, Oxford area, and the San Francisco Bay area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

501-1000 people: larger than 95% of companies with a size listed. 915 people list it on LinkedIn.

Age

201319002026

13 years old.

Reach

Website ranked #812,346 in the world for traffic, about 36k visits a month. 65,393 followers on LinkedIn.

What it does

Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeuticsPharmaceuticalsDrug DiscoveryRare DiseasesDrug RepurposingInflammationImmuno-oncologyDiseases of AgingPhenomicsartificial intelligencemachine learningtechnologybiology

Funding, as listed

$865M raised in total

  • Rounds19
  • LatestPost ipo equity, Jun 2024
  • Latest amountUSD 200,000,000
  • Investors37, 9 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersBlake Borgeson, Chris Gibson, Dean Li
Acquisitions made4

Every detail we hold

Everything the source datasets list about Recursion Pharmaceuticals, field by field. Contact details are held but never shown.

The company

Name
Recursion Pharmaceuticals
Type
For profit
Status
Public · NASDAQ:RXRX
Founded
2013
Founders
Blake Borgeson, Chris Gibson, Dean Li
Industry
Biotechnology Research
Categories
Artificial Intelligence (AI), Biotechnology, Machine Learning, Pharmaceutical, Software, Therapeutics
Specialities
Pharmaceuticals, Drug Discovery, Rare Diseases, Drug Repurposing, Inflammation, Immuno-oncology, Diseases of Aging, Phenomics, artificial intelligence, machine learning, technology, biology, neuroscience, cancer

Where

City
Salt Lake City
Region
Utah
Country
United States
Markets
Western US

Size and reach

Staff band
501-1000
People on LinkedIn
915
LinkedIn followers
65,393
Web traffic rank
#812,346
Monthly web visits
36,185

Funding, as listed

Total
$865,376,000 USD
Rounds
19
Latest round
Post ipo equity
Latest round date
Jun 2024
Latest amount
200,000,000 USD
Investors
37
Lead investors
9
Stock listing
NASDAQ:RXRX
Listing status
public

Corporate family

Acquisitions made
4

About this record

Sources
Crunchbase, LinkedIn
Last imported
Sept 2026

Growth, as the source summarises it

Recursion Pharmaceuticals reported annual earnings that led analysts to lift their estimates. The company also beat expectations in its first quarter 2024 earnings. Additionally, Recursion Pharmaceuticals made a significant executive hire by bringing in J&J's chief data science officer.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

Biotechnology Research in United States.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.